The role of prophylactic cefazolin in the prevention of infection after various types of abdominal wall hernia repair with mesh

Asian Journal of Surgery
Mostafa Mehrabi BaharAli Jangjoo

Abstract

There are controversies about the benefits of prophylactic antibiotics in the prevention of postoperative surgical site infection (SSI) in mesh herniorrhaphy for a long time. This study aimed to evaluate the effectiveness and efficacy of systemic prophylactic cefazolin in prevention of wound infection in various types of hernia repair with mesh materials. This is a prospective randomized control study. We evaluated wound infection rates in 395 patients with various kinds of hernia who underwent elective mesh repair using polypropylene mesh from 2007 to 2011. A total of 237 (60.0%) patients received prophylactic cefazolin (study group) and the remaining 158 (40.0%) patients did not receive any prophylactic antibiotics (control group). Patients were followed for infection at the following periods after the operation by an independent surgeon: 10 days, 30 days, 12 months, and then annually for at least 2 years. Eight (2.03%) patients had infection in the site of surgery [2 (1.27%) in the control group and 6 (2.53%) in the study group]. The distribution of infection was not significantly different between the two groups (p = 0.364). The superficial infections were managed by drainage and irrigation. One patient from the study group...Continue Reading

References

Jan 5, 2002·Hernia : the Journal of Hernias and Abdominal Wall Surgery·A RíosP Parrilla
Sep 25, 2003·Hernia : the Journal of Hernias and Abdominal Wall Surgery·Angel CeldránJosé F Señarís
Dec 22, 2004·American Journal of Surgery·Samir S Awad, Shawn P Fagan
Mar 5, 2008·The British Journal of Surgery·UNKNOWN European Union Network of Excellence (EUNE) for Gastric Cancer Steering Group
Jan 23, 2009·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Juan M BellonJulia Bujan
Jul 29, 2009·Hernia : the Journal of Hernias and Abdominal Wall Surgery·M P SimonsM Miserez
Mar 3, 2010·Journal of the American College of Surgeons·Arthur I GilbertJerrold Young
Sep 20, 2011·Hernia : the Journal of Hernias and Abdominal Wall Surgery·Z ErgulK B Yilmaz
Jan 19, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Dale W BratzlerUNKNOWN Society for Healthcare Epidemiology of America

❮ Previous
Next ❯

Citations

May 23, 2021·Journal of Biomedical Materials Research. Part a·Ángel Serrano-Aroca, Salvador Pous-Serrano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.